New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
10:32 EDTKOOLThermogenesis, TotipotentRX say bone marrow stem cell milestone reached
ThermoGenesis and TotipotentRX Corporation announced earlier that the TotiPotentRX cellular therapy clinical team in partnership with Fortis Healthcare achieved its 20th pediatric bone marrow transplant. ThermoGenesis are up 10% to $2.42 in early trading.
News For KOOL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
06:09 EDTKOOLCesca Therapeutics files IDE application for no-option critical limb ischemia
Cesca Therapeutics has submitted an investigational device exemption application to the FDA for a pivotal multicenter study of the company's SurgWerks-CLI and VXP System for treating advanced stages of no-option lower limb critical limb ischemia. The IDE application is the result of two prior positive pilot and feasibility studies conducted in Italy and India, respectively, and collaborative pre-IDE feedback from the U.S. FDA. The primary endpoint is major amputation free survival at 12 months following enrollment.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use